- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.55 Å
- Oligo State
- hetero-2-4-mer
- Ligands
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 4 residues within 4Å:- Chain A: G.190, E.192, G.256
- Ligands: ADP.1
No protein-ligand interaction detected (PLIP)MG.3: 4 residues within 4Å:- Chain A: S.258, G.260, D.263
- Ligands: ADP.1
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.263, A:D.263, H2O.11, H2O.28
MG.19: 4 residues within 4Å:- Chain D: G.190, E.192, G.256
- Ligands: ADP.18
No protein-ligand interaction detected (PLIP)MG.20: 4 residues within 4Å:- Chain D: S.258, G.260, D.263
- Ligands: ADP.18
4 PLIP interactions:2 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.263, D:D.263, H2O.10, H2O.29
- 6 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
MPD.4: 13 residues within 4Å:- Chain A: S.208, T.212, P.311, V.312, V.315, R.358
- Chain D: L.48, I.147, S.163, G.166, L.167, T.170
- Ligands: ACT.7
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:T.212, A:P.311, A:V.315
- Hydrogen bonds: A:R.358, A:R.358
- Water bridges: A:S.208
MPD.5: 13 residues within 4Å:- Chain A: I.360, L.361, R.387, N.390, R.418, L.419
- Chain D: H.159, R.327, I.332, D.334, T.338
- Ligands: MPD.6, ACT.12
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain A- Hydrogen bonds: D:H.159, A:R.387, A:R.387
- Water bridges: D:R.327, A:N.390
MPD.6: 13 residues within 4Å:- Chain A: R.418, L.419
- Chain D: H.159, H.220, V.323, R.327, P.337, V.415, I.416, R.418
- Ligands: MPD.5, ACT.12, ACT.13
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:R.327
MPD.21: 13 residues within 4Å:- Chain A: L.48, I.147, S.163, G.166, L.167, T.170
- Chain D: S.208, T.212, P.311, V.312, V.315, R.358
- Ligands: ACT.24
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:T.212, D:P.311, D:V.315
- Hydrogen bonds: D:R.358, D:R.358
- Water bridges: D:S.208
MPD.22: 13 residues within 4Å:- Chain A: H.159, R.327, I.332, D.334, T.338
- Chain D: I.360, L.361, R.387, N.390, R.418, L.419
- Ligands: MPD.23, ACT.29
5 PLIP interactions:2 interactions with chain A, 3 interactions with chain D- Hydrogen bonds: A:H.159, D:R.387, D:R.387
- Water bridges: A:R.327, D:N.390
MPD.23: 13 residues within 4Å:- Chain A: H.159, H.220, V.323, R.327, P.337, V.415, I.416, R.418
- Chain D: R.418, L.419
- Ligands: MPD.22, ACT.29, ACT.30
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.327
- 16 x ACT: ACETATE ION(Non-functional Binders)
ACT.7: 7 residues within 4Å:- Chain A: N.310, P.311, V.312
- Chain D: L.48, R.141, D.146
- Ligands: MPD.4
Ligand excluded by PLIPACT.8: 5 residues within 4Å:- Chain A: M.19, T.20, P.21, V.22, R.301
Ligand excluded by PLIPACT.9: 4 residues within 4Å:- Chain A: T.25, A.39, K.156, N.179
Ligand excluded by PLIPACT.10: 5 residues within 4Å:- Chain A: C.152, V.153, L.154, A.155
- Chain D: S.385
Ligand excluded by PLIPACT.11: 2 residues within 4Å:- Chain A: N.195, E.197
Ligand excluded by PLIPACT.12: 8 residues within 4Å:- Chain A: S.388, R.418
- Chain D: G.35, H.159, M.160, G.161
- Ligands: MPD.5, MPD.6
Ligand excluded by PLIPACT.13: 10 residues within 4Å:- Chain D: H.220, N.319, V.323, P.324, R.327, P.337, M.414, V.415, I.416
- Ligands: MPD.6
Ligand excluded by PLIPACT.14: 1 residues within 4Å:- Chain A: E.175
Ligand excluded by PLIPACT.24: 7 residues within 4Å:- Chain A: L.48, R.141, D.146
- Chain D: N.310, P.311, V.312
- Ligands: MPD.21
Ligand excluded by PLIPACT.25: 5 residues within 4Å:- Chain D: M.19, T.20, P.21, V.22, R.301
Ligand excluded by PLIPACT.26: 4 residues within 4Å:- Chain D: T.25, A.39, K.156, N.179
Ligand excluded by PLIPACT.27: 5 residues within 4Å:- Chain A: S.385
- Chain D: C.152, V.153, L.154, A.155
Ligand excluded by PLIPACT.28: 2 residues within 4Å:- Chain D: N.195, E.197
Ligand excluded by PLIPACT.29: 8 residues within 4Å:- Chain A: G.35, H.159, M.160, G.161
- Chain D: S.388, R.418
- Ligands: MPD.22, MPD.23
Ligand excluded by PLIPACT.30: 10 residues within 4Å:- Chain A: H.220, N.319, V.323, P.324, R.327, P.337, M.414, V.415, I.416
- Ligands: MPD.23
Ligand excluded by PLIPACT.31: 1 residues within 4Å:- Chain D: E.175
Ligand excluded by PLIP- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.15: 6 residues within 4Å:- Chain A: V.183, S.246, R.247, A.248, D.249, K.302
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:R.247, A:D.249
- Water bridges: A:V.183, A:K.302, A:K.302
- Salt bridges: A:K.302
PO4.32: 6 residues within 4Å:- Chain D: V.183, S.246, R.247, A.248, D.249, K.302
7 PLIP interactions:7 interactions with chain D- Hydrogen bonds: D:R.247, D:D.249
- Water bridges: D:V.183, D:D.249, D:K.302, D:K.302
- Salt bridges: D:K.302
- 2 x NA: SODIUM ION(Non-functional Binders)
NA.16: 6 residues within 4Å:- Chain A: G.287, L.288, P.289, P.308, N.310, S.313
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:G.287, A:S.313, A:S.313
- Water bridges: A:L.288
NA.33: 6 residues within 4Å:- Chain D: G.287, L.288, P.289, P.308, N.310, S.313
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:G.287, D:S.313
- Water bridges: D:L.288
- 2 x 3F8: 1,1'-[ethane-1,2-diylbis(oxyethane-2,1-diyl)]bis(1H-pyrrole-2,5-dione)(Covalent)
3F8.17: 10 residues within 4Å:- Chain B: Y.8, P.9, C.10
- Chain C: Y.8, P.9, C.10
- Chain D: H.365, Q.366, E.367, P.368
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:Y.8
3F8.34: 10 residues within 4Å:- Chain A: H.365, Q.366, E.367, P.368
- Chain E: Y.8, P.9, C.10
- Chain F: Y.8, P.9, C.10
1 PLIP interactions:1 interactions with chain F- Hydrophobic interactions: F:Y.8
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kasaragod, V.B. et al., Elucidating the Molecular Basis for Inhibitory Neurotransmission Regulation by Artemisinins. Neuron (2019)
- Release Date
- 2019-01-16
- Peptides
- Gephyrin: AD
Gamma-aminobutyric acid receptor subunit alpha-3: BCEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
AB
DC
EE
DF
E
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.55 Å
- Oligo State
- hetero-2-4-mer
- Ligands
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 6 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
- 16 x ACT: ACETATE ION(Non-functional Binders)
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
- 2 x NA: SODIUM ION(Non-functional Binders)
- 2 x 3F8: 1,1'-[ethane-1,2-diylbis(oxyethane-2,1-diyl)]bis(1H-pyrrole-2,5-dione)(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kasaragod, V.B. et al., Elucidating the Molecular Basis for Inhibitory Neurotransmission Regulation by Artemisinins. Neuron (2019)
- Release Date
- 2019-01-16
- Peptides
- Gephyrin: AD
Gamma-aminobutyric acid receptor subunit alpha-3: BCEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
AB
DC
EE
DF
E